NCT00774813View on ClinicalTrials.gov

Nexalin Therapy for the Treatment of Depressive Symptoms

PHASE2CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions
Depression
Interventions
DEVICE

Nexalin 1.3mA Device

"* 3 treatment cycles (cycle is 5 daily treatments, followed by 2 days off)~* Daily receipt of placebo antidepressant"

DEVICE

Nexalin 15mA device

"* 3 treatment cycles (cycle is 5 daily treatments, followed by 2 days off)~* Daily receipt of a placebo antidepressant"

DRUG

placebo device and Citalopram

"* 3 treatment cycles (cycle is 5 daily treatments, followed by 2 days off)~* Daily receipt of a a SSRI (Citalopram or similar)"

Trial Locations (2)

188661

Leningrad Regional Center of Addiction, Saint Petersburg

191187

St. Petersburg City Center of Neuroses, Saint Petersburg

Sponsors
All Listed Sponsors
lead

Kalaco Scientific, Inc.

INDUSTRY

NCT00774813 - Nexalin Therapy for the Treatment of Depressive Symptoms | Biotech Hunter | Biotech Hunter